Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

New research suggests that familial risk of Alzheimer's disease may be higher depending on which parent is affected.

For years, many people with Alzheimer's disease have been diagnosed clinically and confirmed at autopsy. Now Alzheimer's ...

New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...

The failure to diagnose Alzheimer's disease—the most common form of dementia in the elderly—at an early stage of molecular ...

Alzheimer’s disease impacts more than six million Americans, but the exact cause of the devastating condition is still being ...

Light pollution was more strongly correlated with Alzheimer’s disease than some other well-known risk factors.

The FDA’s approval of Kisunla demonstrates a positive change in Alzheimer disease management. Offering illness pathology therapy and the option of treatment conclusion after reaching therapeutic goals ...

A biomedical engineering professor at UMass Amherst is leading a study to help find biomarkers for the cognitive disease, ...